Macquarie Group’s PDS Biotechnology PDSB Stock Holding History

Macquarie Group’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,420	Closed	-$4.16K	–	1846
2024 Q2	$4.16K	Buy	+1,420	New	+$4.54K	﹤0.01%	1732

Other funds holding PDSB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group's PDSB Position: Q3 2024 in Review

Macquarie Group sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 1,420 shares — an estimated $4.16K sold.

Macquarie Group first reported a position in PDSB in Q2 2024 and held it in 1 quarter. The position peaked at $4.16K in Q2 2024. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.

Macquarie Group reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
Macquarie Group sold 1,420 PDS Biotechnology shares in Q3 2024, an estimated $4.16K.
Macquarie Group first reported a position in PDS Biotechnology in Q2 2024 and held it in 1 quarter.
Macquarie Group's PDS Biotechnology position peaked at $4.16K in Q2 2024.
57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.